Close Menu

NEW YORK (GenomeWeb) – Illumina announced today that it has filed two patent infringements lawsuits against five companies in Europe over their use of noninvasive prenatal tests that Illumina claims violate its intellectual property protections.

Illumina filed suit in the UK against The Doctors Laboratory, TDL Genetics, and Ariosa Diagnostics, alleging that The Doctors Laboratory's and TDL Genetics' use of the Harmony NIPT tests supplied by Ariosa infringe on Illumina's European Patent 0 994 963.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A study suggests people with the ApoE e4 genotype may be more likely to have severe COVID-19 than those with other genotypes, the Guardian says.

New analyses indicate female researchers are publishing less during the coronavirus pandemic than male researchers, according to Nature News.

Direct-to-consumer genetic testing companies are searching for a genetic reason for why some people, but not others, become gravely ill with COVID-19, the Detroit Free Press reports.

In PNAS this week: forward genetics-base analysis of retinal development, interactions of T cell receptors with neoantigens in colorectal cancer, and more.